ValuationHello everyone, been here reading most every post for at least 6 years and it feels like I know most of you even having never posted until now. Honestly, there are a lot of super sharp minds on this board and it can be intimidating to join in but here I am! For those of you who may have put a pencil to this, if we secure fda fast track and say we come in with a 60-70% CR from phase 2 with our NMIBC trial, what are we worth on the low side? I know there are other indications and then there's the Covid-19 opportunity ( which by the way, why have we not heard anything more about this ? ) but speaking strictly of NMIBC , what would we be valued at for a buyout ? And how realistic is a buyout and how soon ? I'm sure everyone's laughing at the newbie by now ! So many questions that everyone here wants the answers to ! Just throwing it out there . I could use the money one of these years . Thank you one and all and I promise no politics from this North Carolina medical device sales rep .